NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 15th, 2017 Company Industry JurisdictionCOMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Preferred Stock Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 15th, 2017 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 15th, 2017 Company Industry JurisdictionDEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).